CLOVIS ONCOLOGY INC (NASDAQ:CLVS)

Top Analyst Upgrades and Downgrades: AMD, Apple, Barrick Gold, Domino’s, Intel, McDonald’s, Occidental, Salesforce and More

Posted: August 13, 2019 at 9:05 am

Stocks were indicated to open marginally lower on Tuesday. The market may have taken it on the chin on Monday over trade and currency fears with China, but the 1.2% ...
Read Full Story »

Friday’s Top Analyst Upgrades and Downgrades: Shopify, Qualcomm, Pinterest, Sprouts, BlackLine, Fortinet, Carbon Black and More

Posted: August 2, 2019 at 8:50 am

The stock market was doing well on Thursday following Federal Reserve Chair Jerome Powell’s decision to cut interest rates. However, this was short-lived as President Trump sent the markets tumbling ...
Read Full Story »

Why Clovis Bladder Cancer Treatment Rucaparib Is in Big Trouble

Posted: April 15, 2019 at 10:40 am

Clovis Oncology Inc. (NASDAQ: CLVS) shares dropped on Monday after the firm announced that it would be halting its midstage trial testing its lead drug in bladder cancer patients. Management ...
Read Full Story »

Clovis Oncology Wins Big With European Patent

Posted: December 4, 2018 at 10:05 am

Clovis Oncology Inc. (NASDAQ: CLVS) shares jumped early Tuesday after the European Patent Office upheld the company’s claims. Specifically, the European Patent Office upheld claims of European Patent 2534153 in ...
Read Full Story »

IBM, General Electric Drop into Wednesday’s 52-Week Low Club

Posted: October 31, 2018 at 3:45 pm

October 31, 2018: Here are four stocks trading with heavy volume among 159 equities making new 52-week lows by late afternoon on Wednesday. On the NYSE advancers lead decliners by ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aetna, Baker Hughes, Chesapeake Energy, Cognizant, Cummins, Eli Lilly, GE, Qualcomm, Weatherford and More

Posted: October 31, 2018 at 9:05 am

Stocks were indicated to open much higher on Wednesday after Tuesday's bounce, and earnings may be saving the day, on top of a strong ADP payrolls report. Some investors have ...
Read Full Story »

Keycorp, eBay Drop Into Monday’s 52-Week Low Club

Posted: October 22, 2018 at 2:00 pm

October 22, 2018: Here are four stocks trading with heavy volume among 413 equities making new 52-week lows by midday Monday. On the New York Stock Exchange, decliners lead advancers ...
Read Full Story »

Why Clovis Oncology Faces Some Difficulty With Its Midstage Cancer Study

Posted: October 19, 2018 at 10:10 am

Clovis Oncology Inc. (NASDAQ: CLVS) shares dropped on Friday after the company announced initial data from its Phase 2 TRITON2 clinical trial of Rubraca at the ESMO 2018 Congress of ...
Read Full Story »

Clovis Wins Big With FDA Update

Posted: October 2, 2018 at 12:10 pm

Clovis Oncology Inc. (NASDAQ: CLVS) shares jumped on Tuesday after the U.S. Food and Drug Administration (FDA) gave a critical update. The FDA granted Breakthrough Therapy designation for Rubraca (rucaparib) ...
Read Full Story »

Clovis Finally Faces the Music for Fraudulent Lung Cancer Drug Results

Posted: September 19, 2018 at 1:00 pm

Clovis Oncology Inc. (NASDAQ: CLVS) shares might not be showing it now, but the company is facing some heat from the U.S. Securities and Exchange Commission (SEC). The company, its ...
Read Full Story »

Merrill Lynch Sees 4 Top Biotechs With Key Catalysts in 2018

Posted: September 11, 2018 at 10:55 am

Biotechnology companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single clinical trial could either ...
Read Full Story »

Clovis Breaks Into Europe With EMA Validation

Posted: July 5, 2018 at 8:55 am

Clovis Oncology Inc. (NASDAQ: CLVS) shares saw a bump early on Thursday after the company announced that the European Medicines Agency (EMA) has validated its application for a Type 2 ...
Read Full Story »

3 Stocks to Buy Now With Up to 100% or More Upside Potential

Posted: April 11, 2018 at 8:10 am

One reason that investors continue to do business with full-service brokerage firms is they generate investment ideas, and when they make a call, they typically have solid reasons and a ...
Read Full Story »

Analyst Has 4 Favorite Biotechnology Stocks to Buy Now

Posted: March 15, 2018 at 9:40 am

Biotechnology tends to have very strong up and down moves, and last year the industry reversed the down momentum that started in 2015 and actually outperformed the S&P 500. Many ...
Read Full Story »

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Posted: March 8, 2018 at 11:50 am

Biotechs companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single word from governing health ...
Read Full Story »